.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Merck
Citi
Federal Trade Commission
Harvard Business School
McKesson
QuintilesIMS
Mallinckrodt
Farmers Insurance
Dow

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088389

« Back to Dashboard
NDA 088389 describes LIGNOSPAN FORTE, which is a drug marketed by Deproco and is included in one NDA. It is available from eight suppliers. Additional details are available on the LIGNOSPAN FORTE profile page.

The generic ingredient in LIGNOSPAN FORTE is epinephrine bitartrate; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the epinephrine bitartrate; lidocaine hydrochloride profile page.

Summary for NDA: 088389

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 088389

Suppliers and Packaging for NDA: 088389

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LIGNOSPAN FORTE
epinephrine bitartrate; lidocaine hydrochloride
INJECTABLE;INJECTION 088389 ANDA Septodont 0362-9010 0362-9010-05 50 CARTRIDGE in 1 CARTON (0362-9010-05) > 1.7 mL in 1 CARTRIDGE
LIGNOSPAN FORTE
epinephrine bitartrate; lidocaine hydrochloride
INJECTABLE;INJECTION 088389 ANDA Henry Schein Inc. 0404-6500 0404-6500-15 50 CARTRIDGE in 1 CARTON (0404-6500-15) > 1.7 mL in 1 CARTRIDGE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 0.02MG BASE/ML;2%
Approval Date:Jan 22, 1985TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
McKesson
Baxter
Cantor Fitzgerald
Argus Health
Medtronic
QuintilesIMS
Queensland Health
Federal Trade Commission
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot